200 related articles for article (PubMed ID: 19736994)
1. Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides.
Xu H; Kulkarni KH; Singh R; Yang Z; Wang SW; Tam VH; Hu M
Mol Pharm; 2009; 6(6):1703-15. PubMed ID: 19736994
[TBL] [Abstract][Full Text] [Related]
2. Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.
Qin Z; Li S; Yao Z; Hong X; Wu B; Krausz KW; Gonzalez FJ; Gao H; Yao X
Food Funct; 2018 Mar; 9(3):1410-1423. PubMed ID: 29318243
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides.
Sesink AL; Arts IC; de Boer VC; Breedveld P; Schellens JH; Hollman PC; Russel FG
Mol Pharmacol; 2005 Jun; 67(6):1999-2006. PubMed ID: 15749994
[TBL] [Abstract][Full Text] [Related]
5. UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP.
Jiang W; Xu B; Wu B; Yu R; Hu M
Drug Metab Dispos; 2012 Feb; 40(2):336-45. PubMed ID: 22071170
[TBL] [Abstract][Full Text] [Related]
6. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
7. Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides.
Zeng M; Sun R; Basu S; Ma Y; Ge S; Yin T; Gao S; Zhang J; Hu M
Mol Nutr Food Res; 2016 May; 60(5):1006-19. PubMed ID: 26843117
[TBL] [Abstract][Full Text] [Related]
8. Efflux transport of nicotine, cotinine and trans-3'-hydroxycotinine glucuronides by human hepatic transporters.
Järvinen E; Sjöstedt N; Koenderink JB; Kidron H; Finel M
Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):490-498. PubMed ID: 31237077
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein.
Yang Z; Zhu W; Gao S; Yin T; Jiang W; Hu M
Drug Metab Dispos; 2012 Oct; 40(10):1883-93. PubMed ID: 22736306
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic study on the intestinal absorption and disposition of baicalein.
Zhang L; Lin G; Kovács B; Jani M; Krajcsi P; Zuo Z
Eur J Pharm Sci; 2007 Jul; 31(3-4):221-31. PubMed ID: 17507208
[TBL] [Abstract][Full Text] [Related]
11. Identification of UGTs and BCRP as potential pharmacokinetic determinants of the natural flavonoid alpinetin.
Qi C; Fu J; Zhao H; Xing H; Dong D; Wu B
Xenobiotica; 2019 Mar; 49(3):276-283. PubMed ID: 29436891
[TBL] [Abstract][Full Text] [Related]
12. Human efflux transport of testosterone, epitestosterone and other androgen glucuronides.
Järvinen E; Kidron H; Finel M
J Steroid Biochem Mol Biol; 2020 Mar; 197():105518. PubMed ID: 31704245
[TBL] [Abstract][Full Text] [Related]
13. Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities.
Wang SW; Kulkarni KH; Tang L; Wang JR; Yin T; Daidoji T; Yokota H; Hu M
J Pharmacol Exp Ther; 2009 Jun; 329(3):1023-31. PubMed ID: 19264971
[TBL] [Abstract][Full Text] [Related]
14. Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin.
Liu W; Feng Q; Li Y; Ye L; Hu M; Liu Z
Toxicol Appl Pharmacol; 2012 Dec; 265(3):316-24. PubMed ID: 22982073
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Mediate the Disposition of Leonurine-10-O-β-glucuronide.
Li X; Xie Y; Qu W; Ou X; Ou X; Wang C; Qi X; Wang Y; Liu Z; Zhu L
Curr Drug Metab; 2020; 21(13):1060-1067. PubMed ID: 33198612
[TBL] [Abstract][Full Text] [Related]
16. Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance.
Kemp DC; Fan PW; Stevens JC
Drug Metab Dispos; 2002 Jun; 30(6):694-700. PubMed ID: 12019197
[TBL] [Abstract][Full Text] [Related]
17. Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates.
Jia X; Chen J; Lin H; Hu M
J Pharmacol Exp Ther; 2004 Sep; 310(3):1103-13. PubMed ID: 15128864
[TBL] [Abstract][Full Text] [Related]
18. Effects of P-glycoprotein and Mrp2 inhibitors on the hepatobiliary disposition of Rhodamine 123 and its glucuronidated metabolite in isolated perfused rat livers.
Parasrampuria R; Mehvar R
J Pharm Sci; 2010 Jan; 99(1):455-66. PubMed ID: 19499568
[TBL] [Abstract][Full Text] [Related]
19. Efflux excretion of bisdemethoxycurcumin-O-glucuronide in UGT1A1-overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins 1 (MRP1) as the glucuronide transporters.
Yang J; Zhang B; Qin Z; Li S; Xu J; Yao Z; Zhang X; Gonzalez FJ; Yao X
Biofactors; 2018 Nov; 44(6):558-569. PubMed ID: 30334318
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides.
Jiang H; Yu J; Zheng H; Chen J; Wu J; Qi X; Wang Y; Wang X; Hu M; Zhu L; Liu Z
Pharm Res; 2017 Jul; 34(7):1402-1415. PubMed ID: 28421306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
